TScan Therapeutics Ownership | Who Owns TScan Therapeutics?

Overview Forecast RevenueFinancials Chart

TScan Therapeutics Ownership Summary

TScan Therapeutics is owned by 7.93% institutional investors, 0.23% insiders, and 91.85% retail investors. Lynx1 capital management lp is the largest institutional shareholder, holding 6.06% of TCRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.36% of its assets in TScan Therapeutics shares.

TCRX Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	TScan Therapeutics	7.93%	0.23%	91.85%
Sector	Healthcare Stocks	232.51%	10.72%	-143.22%
Industry	Biotech Stocks	384.55%	10.58%	-295.13%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Lynx1 capital management lp	7.86M	6.06%	$14.30M
Blackrock	4.46M	4.70%	$26.10M
Ecor1 capital	5.00M	4.21%	$15.20M
Bvf inc/il	5.23M	4.03%	$9.51M
Baker bros. advisors lp	2.78M	2.15%	$5.07M
Vanguard group	2.48M	1.91%	$2.48M
Blackrock funding, inc. /de	1.85M	1.42%	$1.85M
Abrdn	1.79M	1.38%	$1.79M
Deer management	1.25M	0.96%	$2.27M
Renaissance	1.14M	0.88%	$1.14M

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
Dc funds, lp	630.00K	36.87%	$1.15M
Lynx1 capital management lp	7.86M	2.91%	$14.30M
Ecor1 capital	5.00M	0.57%	$15.20M
Bvf inc/il	5.23M	0.39%	$9.51M
Deer management	1.25M	0.20%	$2.27M
Militia capital partners, lp	102.10K	0.09%	$185.82K
Tang capital management	600.00K	0.04%	$1.09M
Baker bros. advisors lp	2.78M	0.04%	$5.07M
Dc investments management	35.56K	0.03%	$64.72K
Gsa capital partners llp	226.16K	0.02%	$226.00K

Top Buyers

Holder	Shares	% Assets	Change
Blackrock	4.46M	0.00%	2.76M
Abrdn	1.79M	0.00%	430.42K
Renaissance	1.14M	0.00%	311.15K
Jane street group	388.28K	0.00%	306.97K
Gsa capital partners llp	226.16K	0.02%	226.16K

Top Sellers

Holder	Shares	% Assets	Change
Adage capital partners gp	-	-	-3.50M
Checkpoint capital	-	-	-2.02M
Propel bio management	-	-	-1.93M
Alphabet	-	-	-1.08M
Great point partners	-	-	-1.02M

New Positions

Holder	Shares	% Assets	Change	Value
Gsa capital partners llp	226.16K	0.02%	226.16K	$226.00K
Voleon capital management lp	47.88K	0.00%	47.88K	$87.14K
Acadian asset management	29.54K	-	29.54K	$28.00K
Panagora asset management	25.26K	0.00%	25.26K	$25.26K
Xtx topco	17.63K	0.00%	17.63K	$32.08K

Sold Out

Holder	Change
Ifp advisors	-7.00
True wealth design	-9.00
Eversource wealth advisors	-65.00
Rothschild investment	-110.00
Gamma investing	-142.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Dec 31, 2025	34	-52.78%	10,292,013	-70.26%	7	1.11%	18	-28.00%	9	-67.86%
Sep 30, 2025	72	-4.00%	34,601,233	1.17%	26	3.84%	25	-41.86%	28	64.71%
Jun 30, 2025	78	-12.36%	35,711,883	-7.86%	27	3.08%	46	-6.12%	17	-5.56%
Mar 31, 2025	92	4.55%	40,135,892	-3.36%	30	2.53%	50	6.38%	19	18.75%
Dec 31, 2024	27	-68.60%	11,233,656	-73.15%	9	0.76%	13	-71.11%	5	-68.75%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Vanguard Total Stock Mkt Idx Inv	1.34M	2.36%	-29.61K
Simplify Propel Opportunities ETF	1.05M	1.84%	-
BlackRock Health Sciences Opps Inv A	650.52K	1.15%	-
BlackRock Health Sciences Term Trust	609.80K	1.07%	-435.97K
abrdn Life Sciences Investors	532.24K	0.94%	138.80K
Invesco Dorsey Wright SmallCap Momt ETF	475.53K	0.90%	-
Vanguard Institutional Extnd Mkt Idx Tr	500.00K	0.88%	-206.08K
abrdn Healthcare Investors	498.01K	0.88%	-
Fidelity Small Cap Index	392.73K	0.69%	-
Fidelity Extended Market Index	281.05K	0.50%	-2.31K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Dec 19, 2025	Lynx1 Capital Management LP	-	Buy	$71.97K
Dec 23, 2025	Lynx1 Capital Management LP	-	Buy	$5.60K
Dec 22, 2025	Lynx1 Capital Management LP	-	Buy	$67.95K
May 20, 2025	Lynx1 Capital Management LP	-	Buy	$1.44M
May 19, 2025	Lynx1 Capital Management LP	-	Buy	$1.67M

Insider Transactions Trends

Date	Buy	Sell
2026 Q1	-	-
2025 Q4	3	-
2025 Q3	-	-
2025 Q2	2	-
2025 Q1	-	-

TCRX Ownership FAQ

Who Owns TScan Therapeutics?

TScan Therapeutics shareholders are primarily institutional investors at 7.93%, followed by 0.23% insiders and 91.84% retail investors. The average institutional ownership in TScan Therapeutics's industry, Biotech Stocks , is 384.55%, which TScan Therapeutics falls below.

Who owns the most shares of TScan Therapeutics?

TScan Therapeutics’s largest shareholders are Lynx1 capital management lp (7.86M shares, 6.06%), Blackrock (4.46M shares, 4.70%), and Ecor1 capital (5M shares, 4.21%). Together, they hold 14.97% of TScan Therapeutics’s total shares outstanding.

Does Blackrock own TScan Therapeutics?

Yes, BlackRock owns 4.70% of TScan Therapeutics, totaling 4.46M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 26.1M$. In the last quarter, BlackRock increased its holdings by 2.76M shares, a 162.61% change.

Who is TScan Therapeutics’s biggest shareholder by percentage of total assets invested?

Dc funds, lp is TScan Therapeutics’s biggest shareholder by percentage of total assets invested, with 36.87% of its assets in 630K TScan Therapeutics shares, valued at 1.15M$.

Who is the top mutual fund holder of TScan Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of TScan Therapeutics shares, with 2.36% of its total shares outstanding invested in 1.34M TScan Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools